Allianz Asset Management’s AtriCure ATRC Stock Holding History

Allianz Asset Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.49M	Buy	122,158 +4,342	+4%	+$148K	﹤0.01%	1333
2025 Q4	$4.66M	Buy	117,816 +4,567	+4%	+$167K	﹤0.01%	1168
2025 Q3	$3.99M	Buy	113,249 +2,432	+2%	+$83.8K	﹤0.01%	1211
2025 Q2	$3.63M	Sell	110,817 -12,041	-10%	-$391K	﹤0.01%	1250
2025 Q1	$3.96M	Buy	122,858 +22,838	+23%	+$848K	0.01%	1219
2024 Q4	$3.06M	Buy	100,020 +12,543	+14%	+$403K	﹤0.01%	1257
2024 Q3	$2.45M	Hold	87,477	–	–	﹤0.01%	1342
2024 Q2	$1.99M	Buy	87,477 +9,815	+13%	+$227K	﹤0.01%	1316
2024 Q1	$2.36M	Buy	77,662 +43,581	+128%	+$1.46M	﹤0.01%	1124
2023 Q4	$1.22M	Buy	+34,081	New	+$1.27M	﹤0.01%	1525
2023 Q1	–	Sell	-45,187	Closed	-$2.01M	–	2145
2022 Q4	$2.01M	Hold	45,187	–	–	﹤0.01%	1287
2022 Q3	$1.77M	Hold	45,187	–	–	﹤0.01%	1284
2022 Q2	$1.85M	Buy	+45,187	New	+$2.14M	﹤0.01%	1448
2018 Q1	–	Sell	-150,782	Closed	-$2.75M	–	2621
2017 Q4	$2.75M	Sell	150,782 -32,865	-18%	-$651K	﹤0.01%	1891
2017 Q3	$4.11M	Buy	183,647 +29,153	+19%	+$659K	﹤0.01%	1713
2017 Q2	$3.75M	Buy	154,494 +2,950	+2%	+$62.7K	﹤0.01%	1721
2017 Q1	$2.9M	Sell	151,544 -2,413	-2%	-$42.3K	﹤0.01%	1852
2016 Q4	$3.01M	Sell	153,957 -24,853	-14%	-$450K	﹤0.01%	1819
2016 Q3	$2.83M	Sell	178,810 -16,488	-8%	-$253K	﹤0.01%	1851
2016 Q2	$2.76M	Sell	195,298 -9,400	-5%	-$143K	﹤0.01%	1777
2016 Q1	$3.44M	Sell	204,698 -10,247	-5%	-$180K	﹤0.01%	1585
2015 Q4	$4.82M	Sell	214,945 -7,366	-3%	-$152K	0.01%	1366
2015 Q3	$4.87M	Buy	222,311 +2,984	+1%	+$74.6K	0.01%	1296
2015 Q2	$5.4M	Sell	219,327 -1,764	-0.8%	-$39.4K	0.01%	1350
2015 Q1	$4.53M	Sell	221,091 -27,271	-11%	-$528K	0.01%	1249
2014 Q4	$4.96M	Sell	248,362 -4,432	-2%	-$76.1K	0.01%	1221
2014 Q3	$3.72M	Sell	252,794 -18,026	-7%	-$287K	﹤0.01%	1198
2014 Q2	$4.98M	Buy	270,820 +140,934	+109%	+$2.35M	0.01%	936
2014 Q1	$2.44M	Buy	129,886 +10,005	+8%	+$205K	﹤0.01%	1147
2013 Q4	$2.24M	Buy	+119,881	New	+$1.74M	﹤0.01%	1181

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management's ATRC Position: Q1 2026 in Review

Allianz Asset Management increased its AtriCure (ATRC) stake by 3.7% in Q1 2026, buying an estimated $148K and bringing the position to 122,158 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Allianz Asset Management first reported a position in ATRC in Q4 2013 and has held it in 30 quarters since. The position peaked at $5.4M in Q2 2015. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

Allianz Asset Management held 122,158 shares of AtriCure worth $3.49M as of Q1 2026.
Allianz Asset Management bought 4,342 AtriCure shares in Q1 2026, an estimated $148K.
AtriCure made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1333 holding.
Allianz Asset Management first reported a position in AtriCure in Q4 2013 and has held it in 30 quarters since.
Allianz Asset Management's AtriCure position peaked at $5.4M in Q2 2015.
223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.